Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, N. G.
Right arrow Articles by Minneman, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, N. G.
Right arrow Articles by Minneman, K. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 38, 24624-24632, September 18, 1998


Differential Coupling of alpha 1-, alpha 2-, and beta -Adrenergic Receptors to Mitogen-activated Protein Kinase Pathways and Differentiation in Transfected PC12 Cells*

Nidhi Gupta Williams, Hongying Zhong, and Kenneth P. MinnemanDagger

From the Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Three adrenergic receptor families that selectively activate three different G proteins (alpha 1/Gq/11, alpha 2/Gi, and beta /Gs) were used to study mitogen-activated protein kinase (MAPK) activation and differentiation in PC12 cells. PC12 cells were stably transfected with alpha 1A-, alpha 2A-, or beta 1-adrenergic receptors (ARs) in an inducible expression vector, and subclones were characterized. Norepinephrine stimulated inositol phosphate formation in alpha 1A-transfected cells, inhibited cyclic adenosine 3'5'-monophosphate (cAMP) formation in alpha 2A-transfected cells, and stimulated cAMP formation in beta 1-transfected cells. Nerve growth factor activated extracellular signal-regulated kinases (ERKs) in all cell lines; however, norepinephrine activated ERKs only in alpha 1A- and beta 1-transfected cells but not in alpha 2A-transfected cells. Norepinephrine also activated c-Jun NH2-terminal kinase and p38 MAPK in alpha 1A-transfected cells but not in beta 1- or alpha 2A-transfected cells. Norepinephrine caused differentiation of PC12 cells expressing alpha 1A-ARs but not those expressing beta 1- or alpha 2A-ARs. However, norepinephrine acted synergistically with nerve growth factor in promoting differentiation of cells expressing beta 1-ARs. Whereas ERKs are activated by Gi- but not Gs-linked receptors in many fibroblastic cell lines, we observed the opposite in PC12 cells. The results show that activation of the different G protein signaling pathways has different effects on MAPKs and differentiation in PC12 cells, with Gq signaling pathways activating all three major MAPK pathways.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Although mitogen-activated protein kinase (MAPK)1 pathways were originally thought to be activated primarily by growth factor receptors with intrinsic tyrosine kinase activity, it is now clear that G protein-coupled receptors (GPCRs) can also activate MAPK pathways (1-11). GPCRs acting through Gs (12), Gi (1, 2, 4, 5), and Gq/11 (3, 6-8, 10, 14), have all been shown to activate MAPK, although the mechanisms involved appear to be dependent on cell phenotype. In some cases, MAPK activation is downstream of known second messengers such as cAMP (12), Ca2+ (6, 8), and/or protein kinase C (10). In other cells, Galpha - and/or Gbeta gamma -subunits may directly or indirectly activate the Ras/Raf pathway (1-5, 11) through adapter proteins, tyrosine kinases, and/or phosphoinositide 3 kinase (9). MAPK pathways have been shown to be inhibited by increases in cAMP concentrations in some fibroblastic cell lines (15, 16).

MAPKs are subdivided into three major pathways (17). Extracellular signal regulated kinases 1 and 2 (ERKs) are stimulated by growth factors and cytokines and stimulate growth and differentiation. The proto-oncogene c-ras and the cytoplasmic kinases c-Raf and MEK are known to play important roles in the activation of ERKs (18-20). The other two MAPK pathways, c-Jun-NH2-terminal kinase (JNK) (also known as stress-activated protein kinase) and p38 MAPK, are generally activated by stresses such as inflammatory cytokines, osmotic shock, or UV irradiation and may be involved in inhibition of cell growth and/or apoptosis. The balance between these pathways may be critical in determining cell fate (21).

The mechanisms of activation of ERKs by GPCRs remain controversial. Responses to Gq-linked receptors are thought to involve both the alpha - and beta gamma -subunits of G proteins, although the alpha q-dependent activation of protein kinase C is thought to play the predominant role (3, 22). Response to both Gi-linked (22, 23) and Gs-linked (12) receptors are thought to be due primarily to release of beta gamma -subunits, although other mechanisms have also been proposed (12, 24). Similar mechanisms have been implicated in activation of JNK/SAPK by GPCRs (24, 25), and GPCR activation of p38 MAPK was recently suggested to involve Galpha q- as well as beta gamma -subunits (26). beta gamma -Dependent activation of p38 MAPK is inhibited by coexpression of Galpha o in HEK 293 cells (26).

PC12 cells, derived from a rat pheochromocytoma, have been a primary model for studying mechanisms underlying neuronal differentiation (27). Nerve growth factor (NGF) acts on receptors with tyrosine kinase activity to differentiate these cells into a neuronal phenotype, through a Ras-dependent activation of ERKs (28). Stimulation of both bradykinin (Gq/11-coupled) and lysophosphatidic acid (Gi-coupled) receptors also activates ERKs in PC12 cells, apparently through the tyrosine kinases Pyk2 (6) and Src (8) in a Ras-dependent manner. cAMP analogs also activate ERKs and potentiate NGF-induced neurite formation in PC12 cells (29). Thus, Gq/11-, Gi-, and Gs-linked receptors may all activate ERKs in this cell line.

This raises questions about signaling specificity. If all three types of G proteins can activate ERKs, albeit through different mechanisms, do they have similar functional consequences? To what extent are known second messengers involved in activation of the MAPK pathways? Are the functional consequences of G protein activation similar to those of tyrosine kinase receptor activation?

We wanted to directly address the specificity by which GPCRs activate MAPK pathways in a single cell line and study their functional consequences. To do this, we transfected PC12 cells with inducible expression vectors coding for one of each of the three families (alpha 1A, alpha 2A, and beta 1) of adrenergic receptor (AR) subtypes (30, 31) to assess whether Gq/11-, Gi-, and Gs-linked pathways all activate ERKs in this cell line. ARs affect growth and differentiation of a variety of cell types, although the mechanisms involved are not yet clear. All ARs are activated by norepinephrine (NE), but they initiate signals through different G proteins. alpha 1-ARs increase PI hydrolysis and intracellular Ca2+ through Gq/11, alpha 2-ARs inhibit adenylate cyclase through Gi, and beta -ARs stimulate adenylate cyclase through Gs. We wanted to directly assess which signaling pathways were linked to which MAPK pathways and determine whether activation of any of these GPCRs would cause differentiation of PC12 cells.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Materials-- Materials were obtained from the following sources: Lac-Switch vector system from Stratagene (La Jolla, CA), phentolamine mesylate from Ciba-Geigy (Summit, NJ), hygromycin B from Boehringer Mannheim, BE 2254 ((2-beta -(4-hydroxyphenyl)ethylaminomethyl)-tetralone) from Beiersdorf AG (Hamburg, Germany), cyanopindolol from Sandoz (Basel, Switzerland), [3H]rauwolscine (60 Ci/mmol) and carrier-free Na125I from Amersham Pharmacia Biotech, [3H]inositol (20-40 Ci/mmol) from American Radiolabeled Chemicals (St. Louis, MO), fetal bovine serum, Geneticin, and trypsin/EDTA from Life Technologies, Inc.; and (-)norepinephrine bitartrate, Dulbecco's modified Eagle's medium, penicillin, streptomycin, and other chemicals from Sigma. The cDNA for the human alpha 1A-AR (32) was generously provided by Dr. G. Tsujimoto (National Children's Hospital, Tokyo, Japan), the cDNA for the rat beta 1-AR (33) was provided by Dr. Curtis A. Machida (Oregon Regional Primate Research Center, Beaverton, OR), and the cDNA for the human alpha 2A-AR (34) was obtained from ATCC (Manassas, VA). PC12 cells were obtained from Cindy Miranti and Michael Greenberg (Harvard Medical School, Boston, MA). NGF was generously provided by David Ginty (Johns Hopkins, Baltimore, MD).

Preparation of Expression Vectors-- The full-length AR sequences were cloned into the multiple cloning site of the operator vector (pOPRSVICAT) of the inducible Lac-Switch system. The NotI fragment of pOPRSVICAT containing the chloramphenicol acetyltransferase reporter gene was replaced with the multiple cloning site of pBluescript KS+ (where an additional NotI site had been inserted 5' to the XhoI site) to facilitate insertion of the gene of interest (35).

Cell Culture-- Rat pheochromocytoma PC12 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) horse serum, 5% fetal bovine serum, 10 mg/ml streptomycin, and 100 units/ml penicillin at 37 °C in a humidified atmosphere with 5% CO2. Confluent cells were subcultured in a 1:3 ratio. Where indicated, transfected cells were treated with 1 mM IPTG for various time periods to induce receptor expression.

Transfection-- PC12 cells were co-transfected with the LacSwitch repressor (p3'SS) and operator vectors by calcium phosphate precipitation and propagated for several weeks in the presence of 250 µg/ml hygromycin and 500 µg/ml Geneticin to obtain resistant cells. Subclones expressing each of the different ARs were obtained by screening for cell lines that exhibited low constitutive and high inducible receptor levels by radioligand binding. Cells for radioligand binding and second messenger measurements were plated at lower (<FR><NU>1</NU><DE>10</DE></FR>) antibiotic concentrations.

Radioligand Binding-- Confluent 100-mm plates of cells were washed in phosphate-buffered saline (20 mM NaPO4, 154 mM NaCl, pH 7.6) and harvested by scraping. Cells were homogenized with a Polytron, and membranes collected by centrifugation at 30,000 × g for 10 min, washed, and resuspended by homogenization. Receptor density was determined by saturation analysis of specific antagonist radioligands. Binding of [125I]BE 2254 (alpha 1; [125I]BE), [125I]-iodocyanopindolol (beta ) and [3H]rauwolscine (alpha 2) to membrane preparations was performed as described previously (36-38). For saturation analysis, increasing concentrations of radioligand ([125I]BE, 25-800 pM; [125I]cyanopindolol, 10-300 pM; [3H]rauwolscine, 200-4000 pM) were used. Nonspecific binding was defined as binding in the presence of 10 µM phentolamine (alpha 1 or alpha 2) or 50 µM isoproterenol (beta ).

InsP Formation-- Accumulation of [3H]InsPs was determined in confluent 35-mm dishes. Cells were treated with or without 1 mM IPTG for 48 h and labeled with myo-[3H]inositol (2mCi/plate) for 1-2 days. Production of total [3H]InsPs in the presence of 10 mM LiCl was determined as described previously (35). Results are expressed as percentage of hydrolysis of [3H]inositol incorporated into lipid.

cAMP Accumulation-- cAMP accumulation was measured by the [3H]adenine prelabeling technique in confluent 35-mm dishes as described previously (37). Results are expressed as percent conversion of incorporated [3H]ATP into [3H]cAMP.

Western Blots-- Confluent cells were serum-starved for 2 h at 37 oC before treatment. Agonists were generally added for 15 min, and cells were washed twice with ice-cold phosphate-buffered saline and lysed in Nonidet P-40 lysis buffer containing 137 mM NaCl, 20 mM Tris-Cl (pH 8), 1 mM MgCl2, 1 mM CaCl2, 1% Nonidet P-40, 2 mM phenylmethylsulfonyl fluoride, 20 mM sodium orthovanadate, 20 mM leupeptin, and 10 µg/ml aprotinin. 20 µg of total protein was subjected to SDS-polyacrylamide gel electrophoresis, and proteins were transferred to a nitrocellulose membrane. Activation of ERK1 and 2, JNK/SAPK, or p38 MAPK was detected by blotting the membrane with phosphospecific ERK, JNK/SAPK, or p38 MAPK antibodies (New England Biolabs) that specifically recognize the activated, threonine, and tyrosine dually phosphorylated forms. Blots were stripped and probed with nonphosphospecific antibodies to the enzymes to control for protein loading. Proteins were visualized using a horseradish peroxidase-conjugated goat anti-rabbit IgG and by ECL (Amersham Pharmacia Biotech).

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Lack of Endogenous ARs in Parental PC12 Cells-- We used radioligand binding and functional approaches to determine whether any endogenous ARs are expressed in PC12 cells. Low levels of endogenous alpha 2-ARs have been reported in PC12 cells (39), but we found no detectable levels of any AR subtype in our PC12 cells. No specific binding was detected in membrane preparations using the antagonist radioligands [125I]BE (alpha 1-AR), [3H]rauwolscine (alpha 2 -AR), or [125I]cyanopindolol (beta -AR) (<5 fmol/mg of protein, data not shown). There was also no detectable stimulation of cAMP by the beta -AR agonist isoproterenol, no inhibition of forskolin-stimulated cAMP by the alpha 2-AR agonist UK 14,304 (see also below), and no stimulation of [3H]InsP formation by the alpha 1-AR agonists phenylephrine or NE in parental PC12 cells (data not shown). These data suggest that this is one of the few cell lines that do not express measurable levels of any AR subtype.

Characterization of Stably Transfected PC12 Subclones-- PC12 cells were co-transfected with the lac repressor vector and the lac operator vector containing either human alpha 1A-, human alpha 2A-, or rat beta 1-AR coding sequences. Subclones expressing each receptor were screened for low constitutive expression and inducibility by IPTG. Saturation analysis of specific radioligand binding was used to measure receptor density. Several subclones were isolated with inducible expression of alpha 1A- or alpha 2A-ARs; however, we were unable to obtain subclones showing inducible expression of beta 1-ARs. Several subclones with constitutive expression of beta 1-ARs were isolated and used for further studies. Constitutive and IPTG-induced receptor density in selected subclones is summarized in Table I.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Adrenergic receptor density and properties in subclones of transfected PC12 cells: effect of IPTG induction
PC12 cells were co-transfected with one of the three adrenergic receptor cDNAs subcloned into the LacSwitch operator vector and p3'SS as described in the text. Individual subclones were isolated and propagated as described. Receptor density (Bmax) and affinity (KD) was quantitated by saturation analysis of radioligand (alpha 1A, [125I]BE 2254; alpha 2A, [3H]rauwolscine; beta 1, [125I]iodocyanopindolol) binding to membranes from cells treated with (+IPTG) or without (-IPTG) 1 mM IPTG for 48 h.

alpha 1A-AR Expression and Induction-- Three subclones of PC12 cells expressing alpha 1A-ARs were extensively characterized (Fig. 1). Saturation analysis of [125I]BE binding showed that each subclone exhibited different levels of constitutive and IPTG-induced (1 mM, 48 h) receptor expression, with alpha 1A-3 showing the highest degree of induction. The effect of NE on [3H]InsP formation was studied to ensure that the expressed receptors were functional. Basal [3H]InsP formation was similar in each subclone, and was not affected by treatment with IPTG (Fig. 1). NGF caused small increases in [3H]InsP formation in each subclone, and this response was unaffected by treatment with IPTG. On the other hand, NE increased [3H]InsP formation in each subclone, and this response was substantially increased by induction of receptor expression with IPTG. NE-stimulated [3H]InsP formation was highly correlated with receptor density, being highest in subclone 3, which expressed the highest density of alpha 1A-ARs and lowest in subclone 9, which expressed the lowest density of alpha 1A-ARs (Fig. 1). alpha 1A-AR activation had no effect on cAMP levels (data not shown), showing an absence of cross-talk with Gi or GS.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 1.   Radioligand binding and NE-stimulated inositol phosphate formation in subclones of alpha 1A-transfected PC12 cells. Cells were transfected with the human alpha 1A-AR in the LacSwitch vector system, selected, and propagated as described under "Experimental Procedures." Receptor density (top left) was determined in subclones 3, 9, and 25 treated without (Ctl) or with (Ind) 1 mM IPTG for 48 h by saturation analysis of specific [125I]BE binding. [3H]Inositol phosphate formation was determined in each subclone with or without IPTG induction of receptor expression, in the presence of vehicle (bottom left), 100 µM NE (top right), or 100 ng/ml NGF (bottom right). Each value is the mean ± S.E. of three experiments performed in duplicate.

alpha 2A-AR Expression and Induction-- Two PC12 subclones showing inducible expression of alpha 2A-AR receptors (alpha 2A-2 and alpha 2A-5) were characterized extensively. Saturation analysis of [3H]rauwolscine binding indicated similar levels of basal and IPTG-induced receptor expression in each cell line. The concentration-response curve for IPTG-stimulation of alpha 2A-AR expression in subclone 5 is shown in Fig. 2. IPTG caused about a 7-fold increase in receptor expression with an EC50 around 5-10 µM. Inhibition of forskolin-stimulated cAMP accumulation in these cells by the alpha 2-AR-selective agonist UK 14,304 was used to ensure that the expressed receptors were functional. As expected, there was no effect of IPTG-induced receptor expression on forskolin-stimulated cAMP accumulation (Fig. 2). However, the potency of UK 14,304 in inhibiting forskolin-stimulated cAMP accumulation was enhanced 5-7-fold by IPTG pretreatment (1 mM, 48 h). Interestingly, the maximal inhibition of the forskolin response by UK 14,304 was not affected by IPTG, suggesting that the density of alpha 2A-ARs in uninduced cells is sufficient for maximal inhibition. alpha 2A-AR activation did not affect InsP formation (data not shown), showing an absence of cross-talk with Gq/11.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 2.   Radioligand binding and cAMP accumulation in alpha 2A-5 PC12 subclone. Top, receptor density was determined by saturation analysis of specific [3H]rauwolscine binding in cells treated for 48 h with IPTG at the following concentrations: none (black-square), 5 (black-triangle), 10 (black-down-triangle ), 20 (black-diamond ), 50 (bullet ), 100 (), 1000 (triangle ), or 5000 (down-triangle) µM IPTG. Bottom left, concentration-response relationship for forskolin-stimulated [3H]cAMP formation in cells treated without (-IPTG) or with (+IPTG) 1 mM IPTG for 48 h. Bottom right, concentration-dependent inhibition of 30 µM forskolin-stimulated [3H]cAMP by UK 14,304 in the same cells. Each value is the mean ± S.E. of three experiments performed in duplicate.

beta 1-AR Expression-- All beta 1-AR-expressing PC12 subclones that we isolated showed constitutive receptor expression. Each subclone showed a receptor density around 200 fmol/mg of protein, which was not significantly altered by treatment with IPTG (1 mM, 48 h). Because this receptor density is in the range of expression of the alpha 1A-AR- and alpha 2A-AR-expressing subclones, we used the constitutive expression of subclone beta 1-3 to study beta 1-AR responses in PC12 cells. Because the beta -AR is not activated in the absence of ligand, we did not make further attempts to isolate an inducible beta -AR PC12 cell line. Stimulation with forskolin (30 µM) caused about a 10-fold increase in cAMP accumulation in both parental PC12 cells and the beta 1-3 subclone (Fig. 3). Stimulation with the beta -AR agonist isoproterenol (10 µM) had no effect on cAMP accumulation in parental PC12 cells but caused a significant 50-100% increase in the beta 1-3 subclone. UK 14,304 had no effect on forskolin-stimulated cAMP accumulation in either parental PC12 cells or in the beta 1-3 subclone (Fig. 3), confirming the absence of endogenous alpha 2-ARs. beta 1-AR activation also did not affect InsP formation (data not shown), showing an absence of cross-talk with Gq/11.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 3.   cAMP accumulation in untransfected PC12 cells and in a subclone of PC12 cells transfected with the rat beta 1-AR. Data from untransfected parental PC12 cells is shown in the top panel, and data from the beta 1-3 subclone is shown in the bottom panel. [3H]cAMP accumulation was determined under basal conditions (B) and after stimulation with isoproterenol (ISO, 10 µM), forskolin (F, 30 µM), or forskolin + 10 µM UK 14,304 (F+UK) as described in the text. Each value is the mean ± S.E. of three individual determinations.

Activation of ERKs-- We studied the effect of NE on ERK activation in PC12 cells expressing the different AR subtypes. Exposure to NGF (100 ng/ml) caused activation of ERK 1 and 2 phosphorylation in parental PC12 cells (Fig. 4), as well as in PC12 cells expressing each of the AR subtypes (alpha 1A-3, alpha 2A-5, and beta 1-3). Exposure to NE (100 µM) had no effect in parental PC12 cells but caused activation of ERKs in the alpha 1A-3 PC12 cells (Fig. 4). As expected, the degree of activation of ERKs by NE was increased by increasing alpha 1A-AR expression with IPTG. NE also caused ERK activation in beta 1-3 PC12 cells, although this effect was not increased by IPTG, which does not increase beta 1-AR expression in these cells. Surprisingly, NE had no effect on ERK activation in alpha 2A-5 PC12 cells, even after increasing receptor density by IPTG exposure (Fig. 4). Blotting for total ERK protein showed equivalent sample loading for each condition (Fig. 4). To confirm the lack of alpha 2A-AR-mediated ERK activation in PC12 cells, the effect of NE was also tested on the alpha 2A-2 subclone. Again, NGF increased ERK phosphorylation in this cell line, whereas NE had no effect either with or without exposure to IPTG (data not shown).


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 4.   Activation of MAPK by NE and NGF in PC12 cell subclones. Cells were treated with (+) or without (-) 1 mM IPTG for 48 h; serum-starved for 2 h; treated with vehicle (C), NE (100 µM), or NGF (100 ng/ml) for 15 min; lysed; and harvested as described. 20 µg of protein from each sample was subjected to SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose, and blotted for activated phosphorylated MAPK (P-MAPK) or total MAPK (MAPK) as described. Data from parental PC12 cells and subclones transfected with each of the three AR subtypes are shown. Data are representative of seven or more separate experiments.

Activation of JNK/SAPK-- Several GPCRs have also been shown to activate JNK/SAPK in various cells (7, 40). Exposure to NGF (100 ng/ml) caused a slight activation of JNK phosphorylation in alpha 1A-3, alpha 2A-2, and beta 1-3 PC12 cells (Figs. 5 and 6). Exposure to NE (100 µM) caused a significant activation of JNK in the alpha 1A-3 PC12 cells, and the effect of NE was markedly increased by increasing alpha 1A-AR expression with IPTG (Fig. 5). NE had no significant effect on JNK activation in alpha 2A-2 or beta 1-3 PC12 cells, irrespective of IPTG pretreatment (Fig. 6).


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 5.   Activation of JNK/SAPK and p38 MAPK by NE and NGF in alpha 1A-3 PC12 cells. Cells were treated with (+IPTG) or without (-IPTG) 1 mM IPTG for 48 h; serum-starved for 2 h; treated with vehicle (C), NE (100 µM), or NGF (100 ng/ml) for 15 min; lysed; and harvested as described. 20 µg of protein from each sample was subjected to SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose, and blotted for activated phosphorylated JNK (P-JNK), activated phosphorylated p38 MAPK (P-p38), or total p38 MAPK (p38) as described. Data are representative of five or more separate experiments.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 6.   Summary of the effects of NE and NGF on activation of MAPK pathways in PC12 cells stably expressing different AR subtypes. The degree of activation of MAPK (P-MAPK), JNK (P-JNK), and p38 MAPK (P-p38) by NE (100 µM) or NGF (100 ng/ml) was quantitated by densitometry of Western blots. Data from PC12 cell subclones stably transfected with alpha 1A-AR (top), alpha 2A-AR (middle), or beta 1-AR (bottom) subtypes is shown. Each value is the mean ± S.E. of values from 3-7 experiments. Bars indicate basal intensity in the absence of agonist (100%).

Activation of p38 MAPK-- GPCRs have also been shown to activate p38 MAPK in certain cells (26). Exposure to NGF (100 ng/ml) caused only a small activation of p38 MAPK phosphorylation in alpha 1A-3, alpha 2A-2, and beta 1-3 PC12 cells (Figs. 5 and 6). Exposure to NE (100 µM) caused a significant activation of p38 MAPK in the alpha 1A-3 PC12 cells, and the effect of NE was again markedly increased by increasing alpha 1A-AR expression with IPTG (Fig. 5). NE had no significant effect on p38 MAPK activation in alpha 2A-2 or beta 1-3 PC12 cells, irrespective of IPTG pretreatment (Fig. 6). Blotting for total p38 MAPK protein showed equivalent protein loading in all samples.

Summary of AR-mediated Activation of MAPK Pathways in PC12 Subclones-- Fig. 6 shows a summary of the effects of NE and NGF on activation of ERKs, JNK/SAPK, and p38 MAPK in the alpha 1A-3, alpha 2A-2, alpha 2A-5, and beta 1-3 PC12 subclones. NGF caused substantial increases in ERK activation and small increases in JNK/SAPK and p38 MAPK activation in all cell lines studied. NE caused an 8.6-fold activation of ERKs, 5.3-fold activation of JNK/SAPK, and 2.2-fold increase in p38 MAPK activation in IPTG-induced alpha 1A-3 PC12 cells. NE caused no detectable increase in activation of ERKs, JNK/SAPK, or p38 MAPK in either of the alpha 2A PC12 subclones examined, either with or without IPTG treatment. NE caused a 3-fold increase in ERK activation, but no detectable increase in either JNK/SAPK or p38 MAPK in beta 1-3 PC12 cells.

Time Course of NE-stimulated ERK Activation in alpha 1A and beta 1-AR PC12 Cells-- Because activation of either alpha 1A- or beta 1-ARs activated ERKs in PC12 cells, we compared the time course of the two responses. Fig. 7 shows that NE activation of alpha 1A-ARs caused a large and sustained activation of ERKs, which was highly dependent on receptor induction by IPTG. NE activation of beta 1-ARs also caused sustained ERK activation.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 7.   Time course for NE activation of ERKs in PC12 subclones. alpha 1A-3 PC12 cells were treated with (bullet , Induced) or without (open circle , Control) 1 mM IPTG for 48 h, and beta 1-3 cells () were cultured without IPTG. Cells were serum-starved for 2 h, treated with NE (100 µM) for 0-120 min, lysed, and harvested as described. 20 µg of protein from each sample was subjected to SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose, and blotted for activated phosphorylated MAPK as described. Data are representative of two separate experiments. The degree of stimulation is expressed in arbitrary units and is relative to basal intensity. The densitometer was adjusted for maximal sensitivity to emphasize responses.

Differentiation of AR-expressing PC12 Cells-- Exposure of alpha 1A-3 PC12 cells to either NE or NGF caused differentiation of the cells within 36-48 h after exposure (Fig. 8). The extent of NE-induced differentiation of alpha 1A-3 PC12 cells was dependent on the level of receptor expression. Cells expressing high levels of alpha 1A-ARs (~300 fmol/mg of protein following induction with IPTG) displayed NE-induced differentiation similar to that observed with NGF alone, whereas cells expressing lower levels of alpha 1A-ARs (~40 fmol/mg of protein, not induced with IPTG) showed NE-induced differentiation only slightly higher than untreated cells. Exposure of IPTG-induced alpha 1A-3 cells to both NE and NGF caused differentiation levels (size and number of neurites) greater than those caused by either agonist alone (Fig. 8), suggesting that differentiation in response to the two agonists is additive. Exposure of uninduced alpha 1A-3 cells to both NE and NGF caused differentiation similar to that of cells exposed to NGF alone, confirming that the effects of NE and NGF are additive, not synergistic.


View larger version (124K):
[in this window]
[in a new window]
 
Fig. 8.   Effects of NE and NGF on differentiation of the alpha 1A-3 subclone of PC12 cells. Cells were plated on collagen-coated plates and treated without (A, C, E, and G) or with (B, D, F, and H) 1 mM IPTG for 48 h to induce receptor expression. Before treatment with agonists, the medium was replaced with Dulbecco's modified Eagle's medium containing 1% horse serum. Cells were then treated for 48 h with vehicle (A and B), 10 µM NE (C and D), 100 ng/ml NGF (E and F), or NE + NGF (G and H). Fresh NE was added every 24 h. A representative field of cells is shown in each case.

NE treatment had no significant effect on the differentiation state of either of the alpha 2A-AR-expressing PC12 subclones (subclones 2 and 5), either with or without induction of receptor expression with IPTG (1 mM, 48 h), in the presence or absence of NGF, or at any time point examined (data not shown).

Exposure of beta 1-3 PC12 cells to NE for 24-36 h had little visible effect on differentiation (Fig. 9). However, NE had a synergistic effect on differentiation caused by NGF. Exposure to both NGF and NE for just 24 h caused differentiation of cells to levels higher than that seen in cells exposed to either NGF or NE alone (Fig. 9).


View larger version (67K):
[in this window]
[in a new window]
 
Fig. 9.   Effects of NE and NGF on differentiation of the beta 1-3 subclone of PC12 cells. Cells were plated on collagen-coated plates. Before treatment with agonists, the medium was replaced with Dulbecco's modified Eagle's medium containing 1% horse serum. Cells werethe treated for 24-30 h with vehicle (A), 100 µM NE (B), 100 ng/ml NGF (C), or NE + NGF (D). Fresh NE was added every 24 h. A representative field of cells is shown in each case.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

In this report, we directly compare the effects of Galpha q/11, Galpha i, and Galpha S-coupled ARs on mitogenic responses and differentiation of PC12 cells. ARs affect growth and differentiation of many cells, although the subtypes and mechanisms involved are not yet clear. PC12 cells have been widely used to study the events involved in cellular differentiation (27). NGF causes differentiation of PC12 cells through a sustained activation of the Ras/Raf/ERK pathway (21, 28). We took advantage of the fact that the three AR families selectively couple to three major G protein families (alpha 1/Gq/11, alpha 2/Gi, and beta /GS) to examine the specificity with which these receptors activate MAPK in PC12 cells. Because receptor density is critically important in signaling specificity, we used an IPTG-inducible vector system to control receptor expression within a range normally observed in many tissues. We wanted to directly compare AR-mediated activation of Gq/11, Gi, and GS on MAPK and differentiation responses in the same cellular phenotype. PC12 cells also allow direct comparison of signals generated by GPCRs and tyrosine kinase receptors involved in growth, differentiation, and apoptosis.

We found dramatic differences in the ability of the three AR families to promote MAPK activation and differentiation of PC12 cells. Stimulation of both alpha 1A- and beta 1-ARs caused ERK activation, whereas stimulation of alpha 2A-ARs did not. The activation of ERKs by alpha 1A- and beta 1-ARs was sustained and elevated even 1 h after stimulation. Only in alpha 1A-AR transfected cells did NE cause significant activation of the JNK/SAPK and p38 MAPK pathways. In addition, only the alpha 1A-AR subtype caused PC12 differentiation in the absence of other stimuli. Most surprisingly, activation of alpha 2A-ARs at either low or high density had no effect on ERK activation in PC12 cells, despite previous studies showing activation of this pathway through the endogenous lysophosphatidic acid receptor in these cells (6, 8).

Activation of alpha 1A-ARs by NE caused a substantial activation of ERKs in PC12 cells, and this effect was increased by IPTG exposure, suggesting that it was proportional to receptor density. ERK activation by alpha 1A-ARs corresponded with a NE-induced differentiation of these cells into a neuronal-like phenotype. In cells expressing high levels of alpha 1A-ARs, NE caused differentiation indistinguishable from that caused by NGF. Differentiation of alpha 1A-AR cells exposed to both NGF and NE was no more than additive and occurred on the same time scale as that caused by NGF alone (36-48 h).

NE also caused a large activation of JNK/SAPK and a smaller activation of p38 MAPK in alpha 1A-transfected PC12 cells, and these responses were also increased by IPTG exposure. alpha 1-AR-mediated activation of JNK/SAPK has been reported in cardiomyocytes (40); however, activation of p38 MAPK by alpha 1-ARs has not been reported previously. p38 MAPK has been shown to be activated by Gq/11-coupled m1 muscarinic receptors (26) and by activated forms of alpha q (14). Activation of JNK/SAPK and p38 MAPK has previously been associated with stress responses (17, 21); however, recent data in cardiomyocytes suggest a role for JNK in cell growth (40). In most cases, ERK, JNK/SAPK, and p38 MAPK pathways are activated by different stimuli (17), and alpha 1A-transfected PC12 cells are unusual in activation of these pathways by a single stimulus.

GPCRs coupling through alpha i (including alpha 2-ARs) were among the first GPCRs shown to activate ERKs (1, 2, 4). Other alpha i-coupled receptors, such as lysophosphatidic acid receptors, have also been reported to activate ERKs in PC12 cells (8). We were surprised to find that stimulation of alpha 2A-ARs did not activate ERKs in PC12 cells, even at high expression levels. Studies on inhibition of forskolin-stimulated cAMP accumulation showed that the expressed alpha 2A-ARs were functional, and receptor density in the presence of IPTG was higher for alpha 2A-ARs than either alpha 1A- or beta 1-ARs (Table I). Although lysophosphatidic acid often acts via alpha i, it has also been reported to activate alpha q in PC12 cells (41, 42), and it could be causing at least some of its effects via alpha q in these cells.

The fact that alpha 2A-ARs activate ERKs in fibroblastic cell lines such as Rat1a cells (2, 4) in a PTX-sensitive manner but do not activate ERKs in PC12 cells indicates that there are important mechanistic differences in signaling between the cell types. Activation of ERKs by Gi-linked receptors appears to be mediated by beta gamma -subunits (3, 22, 23, 43), and recent work suggests that beta gamma signaling is impaired in the presence of either alpha t- or alpha o-subunits (3, 44, 45). alpha o is selectively expressed in brain and many neuronal cell lines, including PC12 cells (39, 46, 47). Fibroblastic cell lines, such as NIH3T3 and Rat1a, express alpha i2 and alpha i3 but not alpha o (39). Because alpha o is expressed selectively in PC12 cells, it may play a similar suppressive role in beta gamma -mediated MAPK activation by alpha 2A-ARs. Regardless, our results show that ERK activation is not a universal response to activation of Gi-coupled receptors in PC12 cells.

Release of beta gamma -subunits is also proposed to be important for ERK activation by alpha S-linked GPCRs, although the specificity of these interactions in PC12 cells is not yet clear (12, 43, 48). The effects of increased levels of cAMP on differentiation of PC12 cells and activation of ERKs have been well studied (29, 49, 50). In most other cell lines, increases in cAMP generally inhibit ERK activation (15, 16), and PC12 cells are relatively unusual in that forskolin-induced increases in cAMP activate ERKs (29, 49-51). This study is one of the few examples of ERK activation in PC12 cells caused by stimulation of an alpha s-linked GPCR (rather than direct increases in cAMP), which would involve signaling from both alpha S- and beta gamma -subunits. We observed sustained activation of ERKs upon stimulation of beta 1-ARs in PC12 cells without observable differentiation in the absence of NGF. However, beta 1-AR activation strongly potentiated NGF-induced differentiation, causing the appearance of neurites within 24 h after addition of both NE and NGF. This is consistent with previous studies suggesting that large increases in cAMP can alone cause differentiation of PC12 cells, but smaller increases in cAMP only potentiate growth factor-induced differentiation (52). Intracellular nonmitochondrial Ca2+ pools have been shown to be necessary for the synergistic effects of NGF and cAMP analogs on PC12 cell differentiation (53).

Previous studies in which PC12 cells were transfected with activated forms of G protein alpha -subunits showed that activated forms of alpha q alone, but not of alpha i or alpha o, were capable of differentiating PC12 cells (14). Differentiation by alpha q coincided with activation of JNK, but ERK activation was not seen (14). The results using activated alpha S are less clear. One group reported that expression of activated alpha S caused proliferation of PC12 cells and constitutive activation of cAMP dependent pathways (54), whereas another group found that expression of activated alpha S caused differentiation of PC12 cells (55). Transfection of G protein subunits into Cos7 cells showed that ERK activation may be due to signaling from beta gamma rather than either alpha q, alpha i, or alpha S (3).

These results have some similarities to studies in cardiac and smooth muscle, in which both alpha 1- and beta -ARs are involved in growth and differentiation (56). In both cases, alpha 1-ARs dominate, causing rapid and divergent activation of MAPK pathways and transcription (40, 56-60). Because stimulation of alpha 1A-ARs activates ERKs, JNK/SAPK, and p38 MAPK and promotes differentiation of PC12 cells, it will be interesting to compare the signaling pathways involved with those in myocytes (13, 60, 61). Studies in cardiac and smooth muscle cells are generally performed in primary cultures or in vivo, and PC12 cells may be a useful alternative in defining the transcriptional effects of receptor activation and how they relate to growth and differentiation.

This report shows that activations of alpha 1-, alpha 2-, and beta -ARs in transfected PC12 cells have different effects on MAPK pathways and differentiation, suggesting a clear specificity in activation of MAPK pathways. The marked stimulation of all three MAPK pathways and differentiation by alpha 1A-AR activation may provide a useful system for studying the mechanisms by which GPCRs control cellular growth and differentiation and the relationship of these pathways to those activated by tyrosine kinase receptors.

    FOOTNOTES

* This research was supported by National Institutes of Health Grants NS32706 and NS23756 (to K. P. M.) and Fellowship NS09580 (to N. G. W.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 404-727-5985; Fax: 404-727-0365.

The abbreviations used are: MAPK, mitogen-activated protein kinase; AR, adrenergic receptor; cAMP, cyclic adenosine 3'5'-monophosphate; ERK, extracellular signal-regulated kinase (also known as p42 and p44 MAPKs); GPCR, G protein-coupled receptor; [125I]BE, [125I]BE 2254 ((2-beta -(4-hydroxyphenyl)ethylaminomethyl)-tetralone)InsP, inositol phosphateIPTG, isopropylthiogalactoseJNK, c-Jun NH2-terminal kinaseNE, norepinephrineNGF, nerve growth factorSAPK, stress-activated protein kinase.
    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Howe, L. R., and Marshall, C. J. (1993) J. Biol. Chem. 268, 20717-20720[Abstract/Free Full Text]
  2. Alblas, J., van Corven, E. J., Hordijk, P. L., Milligan, G., and Moolenaar, W. H. (1993) J. Biol. Chem. 268, 22235-22238[Abstract/Free Full Text]
  3. Crespo, P., Xu, H., Simonds, W. F., and Gutkind, J. S. (1994) Nature 369, 418-420[CrossRef][Medline] [Order article via Infotrieve]
  4. Winitz, S., Russell, M., Qian, N.-X., Gardner, A., Dwyer, L., and Johnson, G. L. (1993) J. Biol. Chem. 268, 19196-19199[Abstract/Free Full Text]
  5. Van Bliesen, T., Hawes, B. E., Luttrell, D. K., Krueger, K. M., Touhara, K., Porfiri, E., Sakaue, M., Luttrell, L. M., and Lefkowitz, R. L. (1995) Nature 376, 781-784[CrossRef][Medline] [Order article via Infotrieve]
  6. Lev, S., Moreno, H., Martinez, R., Canoll, P., Peles, E., Musacchio, J. M., Plowman, G. D., and Schlessinger, J. (1995) Nature 376, 737-745[CrossRef][Medline] [Order article via Infotrieve]
  7. Coso, O. A., Chiariello, M., Kalinec, G., Kyriakis, J. M., Woodgett, J., and Gutkind, J. S. (1995) J. Biol. Chem. 270, 5620-5624[Abstract/Free Full Text]
  8. Dikic, I., Tokiwa, G., Lev, S., Courtneidge, S. A., and Schlessinger, J. (1996) Nature 383, 547-550[CrossRef][Medline] [Order article via Infotrieve]
  9. Lopez-Ilasaca, M., Crespo, P., Pellici, P. G., Gutkind, J. S., and Wetzker, R. (1997) Science 275, 394-397[Abstract/Free Full Text]
  10. Della Rocca, G. J., van Biesen, T., Daaka, Y., Luttrell, D. K., Luttrell, L. M., and Lefkowitz, R. J. (1997) J. Biol. Chem. 272, 19125-19132[Abstract/Free Full Text]
  11. Sugden, P. H., and Clerk, A. (1997) Cell. Signal. 9, 337-351[CrossRef][Medline] [Order article via Infotrieve]
  12. Crespo, P., Cachero, T. G., Xu, N., and Gutkind, J. S. (1995) J. Biol. Chem. 270, 25259-25265[Abstract/Free Full Text]
  13. Thorburn, J., and Thorburn, A. (1994) Biochem. Biophys. Res. Commun. 202, 1586-1591[CrossRef][Medline] [Order article via Infotrieve]
  14. Heasley, L. E., Storey, B., Fanger, G. R., Butterfield, L., Zamarripa, J., Blumberg, D., and Maue, R. A. (1996) Mol. Cell. Biol. 16, 648-656[Abstract]
  15. Cook, S. J., and McCormick, F. (1993) Science 262, 1069-1072[Abstract/Free Full Text]
  16. Wu, J., Dent, P., Jelinek, T., Wolfman, A., Weber, M. J., and Sturgill, T. W. (1993) Science 262, 1065-1069[Abstract/Free Full Text]
  17. Robinson, M. J., and Cobb, M. H. (1997) Curr. Opin. Cell Biol. 9, 180-186[CrossRef][Medline] [Order article via Infotrieve]
  18. Williams, N. G., Roberts, T. M., and Li, P. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 2922-2926[Abstract/Free Full Text]
  19. Williams, N. G., Paradis, H., Agarwal, S., Charest, D. L., Pelech, S. L., and Roberts, T. M. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 5772-5776[Abstract/Free Full Text]
  20. Williams, N. G., and Roberts, T. M. (1994) Cancer Metastasis Rev. 13, 105-116[CrossRef][Medline] [Order article via Infotrieve]
  21. Xia, Z., Dickens, M., Rangeaud, J., Davis, R. J., and Greenberg, M. E. (1995) Science 270, 1326-1331[Abstract/Free Full Text]
  22. Hawes, B. E., van Biesen, T., Koch, W. J., Luttrell, L. M., and Lefkowitz, R. J. (1995) J. Biol. Chem. 270, 17148-17153[Abstract/Free Full Text]
  23. Koch, W. J., Hawes, B. E., Allen, L. F., and Lefkowitz, R. J. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 12706-12710[Abstract/Free Full Text]
  24. Daaka, Y., Luttrell, L. M., and Lefkowitz, R. J. (1997) Nature 390, 88-91[CrossRef][Medline] [Order article via Infotrieve]
  25. Prasad, M. V. V. S. V., Dermott, J. M., Heasley, L. E., Johnson, G. L., and Dhanasekaran, N. (1995) J. Biol. Chem. 270, 18655-18659[Abstract/Free Full Text]
  26. Yamauchi, J., Nagao, M., Kaziro, Y., and Itoh, H. (1997) J. Biol. Chem. 272, 27771-27777[Abstract/Free Full Text]
  27. Wood, K. W., and Roberts, T. M. (1992) Biochim. Biophys. Acta 1155, 133-150
  28. Lange-Carter, C. A., and Johnson, G. L. (1994) Science 265, 1458-1461[Abstract/Free Full Text]
  29. Frodin, M., Peraldi, P., and van Obberghen, E. (1994) J. Biol. Chem. 269, 6207-6214[Abstract/Free Full Text]
  30. Bylund, D. B., Eikenberg, D. C., Hieble, J. P., Langer, S. Z., Lefkowitz, R. J., Minneman, K. P., Molinoff, P.B., Ruffolo, R. R., and Trendelenberg, U. J. (1994) Pharmacol. Rev. 46, 121-136[Medline] [Order article via Infotrieve]
  31. Minneman, K. P., and Esbenshade, T. A. (1994) Annu. Rev. Pharmacol. Toxicol. 34, 117-133[Medline] [Order article via Infotrieve]
  32. Hirasawa, A., Horie, K., Tanaka, T., Takagaki, K., Murai, M., Yano, J., and Tsujimoto, G. (1993) Biochem. Res. Commun. 195, 902-909
  33. Machida, C. A., Brunzow, J. R., Searles, R. P., van Tol, H., Tester, B., Neve, K. A., Teal, P., Nipper, V., and Civelli, O. (1990) J. Biol. Chem. 265, 12960-12965[Abstract/Free Full Text]
  34. Kobilka, B. K., Matsui, H., Kobilka, T. S., Yang-Feng, T. L., Francke, U., Caron, M. G., Lefkowitz, R. J., and Regan, J. W. (1987) Science 238, 650-656[Abstract/Free Full Text]
  35. Esbenshade, T. A., Han, C., Murphy, T. J., and Minneman, K. P. (1993) Mol. Pharmacol. 44, 76-86[Abstract]
  36. Nasseri, A., and Minneman, K. P. (1987) Mol. Pharmacol. 32, 655-662[Abstract]
  37. Zhong, H., and Minneman, K. P. (1993) Mol. Pharmacol. 44, 1085-1093[Abstract]
  38. Gatti, G., Madeddu, L., Pandiella, A., Pozzan, T., and Meldolesi, J. (1988) Biochem. J. 255, 753-760[Medline] [Order article via Infotrieve]
  39. Duzic, E., and Lanier, S. M. (1992) J. Biol. Chem. 267, 24045-24052[Abstract/Free Full Text]
  40. Ramirez, M. T., Sah, V. P., Zhao, X.-L., Hunter, J. J., Chien, K. R., and Brown, J. H. (1977) J. Biol. Chem. 272, 14057-14061[Abstract/Free Full Text]
  41. Tigyi, G., Fischer, D. J., Sebok, A., Marshall, F., Dyer, D. L., and Miledi, R. (1996) J. Neurochem. 66, 549-558[Medline] [Order article via Infotrieve]
  42. Van Corven, E. J., Gooenink, A., Jalink, K., Eichholtz, T., and Moolenaar, W. H. (1989) Cell 59, 45-54[CrossRef][Medline] [Order article via Infotrieve]
  43. Faure, M., Voyno-Yasenetskaya, T. A., and Bourne, H. R. (1994) J. Biol. Chem. 269, 7851-7854[Abstract/Free Full Text]
  44. Yamauchi, J., Kaziro, Y., and Itoh, H. (1997) J. Biol. Chem. 272, 7602-7607[Abstract/Free Full Text]
  45. Ito, A., Satoh, T., Kaziro, Y., and Itoh, H. (1995) FEBS Lett. 368, 183-187[CrossRef][Medline] [Order article via Infotrieve]
  46. Baribay, J. L., Kozasa, T., Itoh, H., Tsukamoto, T., Matsuoka, M., and Kaziro, Y. (1991) Biochim. Biophys. Acta 1094, 193-199[Medline] [Order article via Infotrieve]
  47. Asano, T., Morishita, R., and Kato, K. (1992) J. Neurochem. 58, 2176-2181[Medline] [Order article via Infotrieve]
  48. Hamm, H. (1998) J. Biol. Chem. 273, 669-672[Free Full Text]
  49. Gunning, P. W., Landreth, G. E., Bothwell, M. A., and Shooter, E. M. (1981) J. Cell Biol. 89, 240-245[Abstract/Free Full Text]
  50. Damon, D. H., D'Amore, P. A., and Wagner, J. A. (1990) J. Cell Biol. 110, 1333-1339[Abstract/Free Full Text]
  51. Traverse, S., Gomez, H., Paterson, H., Marshall, C., and Cohen, P. (1992) Biochem. J. 288, 351-355
  52. Mark, M. D., and Storm, D. R. (1977) J. Biol. Chem. 272, 17238-17244[Abstract/Free Full Text]
  53. Huang, C. M., Tsay, K. E., and Kao, L. S. (1996) J. Neurochem. 67, 530-539[Medline] [Order article via Infotrieve]
  54. Gaiddon, C., Boutillier, A., Monnier, D., Mercken, L., and Loeffler, J. (1994) J. Biol. Chem. 269, 22663-22671[Abstract/Free Full Text]
  55. Kabir, A. M., Kozasa, T., Kaziro, Y., and Nakamura, S. (1993) Cell. Signalling 5, 443-452[CrossRef][Medline] [Order article via Infotrieve]
  56. Simpson, P. C., Kariya, K-I., Karns, L. R., Long, C. S., and Karliner, J. S. (1991) Mol. Cell. Biochem. 104, 35-43[Medline] [Order article via Infotrieve]
  57. Thorburn, A., Thorburn, J., Chen, S.-Y., Powers, S., Shubeita, H. E., Feramisco, J. R., and Chien, K. R. (1993) J. Biol. Chem. 268, 2244-2249[Abstract/Free Full Text]
  58. LaMorte, V. J., Thorburn, J., Absher, D., Spiegel, A., Brown, J. H., Chien, K. R., Feramisco, J. R., and Knowlton, K. U. (1994) J. Biol. Chem. 269, 13490-13496[Abstract/Free Full Text]
  59. Xin, X., Yang, N., Eckhart, A. D., and Faber, J. E. (1997) Mol. Pharmacol. 51, 764-775[Abstract/Free Full Text]
  60. Bogoyevitch, M. A., Andersson, M. B., Gillespie-Brown, J., Clerk, A., Glennon, P. E., Fuller, S. J., and Sugden, P. H. (1996) Biochem. J. 314, 115-121
  61. Sah, V. P., Hoshijima, M., Chien, K. R., and Brown, J. H. (1996) J. Biol. Chem. 271, 31185-31190[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. Zhang and A. A. Abdel-Rahman
Inhibition of Nischarin Expression Attenuates Rilmenidine-Evoked Hypotension and Phosphorylated Extracellular Signal-Regulated Kinase 1/2 Production in the Rostral Ventrolateral Medulla of Rats
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 72 - 78.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Gericke, P. Martinka, I. Nazarenko, P. B. Persson, and A. Patzak
Impact of {alpha}1-adrenoceptor expression on contractile properties of vascular smooth muscle cells
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1215 - R1221.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Askari, R. Diskin, M. Avitzour, R. Capone, O. Livnah, and D. Engelberg
Hyperactive Variants of p38{alpha} Induce, whereas Hyperactive Variants of p38{gamma} Suppress, Activating Protein 1-mediated Transcription
J. Biol. Chem., January 5, 2007; 282(1): 91 - 99.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. B. Gibson, M. C. Lawrence, C. J. Gibson, C. A. Vanderbilt, K. McGlynn, D. Arnette, W. Chen, J. Collins, B. Naziruddin, M. F. Levy, et al.
Inhibition of Glucose-Stimulated Activation of Extracellular Signal-Regulated Protein Kinases 1 and 2 by Epinephrine in Pancreatic {beta}-Cells.
Diabetes, April 1, 2006; 55(4): 1066 - 1073.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. D. Peavy, K. B. Hubbard, A. Lau, R. B. Fields, K. Xu, C. J. Lee, T. T. Lee, K. Gernert, T. J. Murphy, and J. R. Hepler
Differential Effects of Gq{alpha}, G14{alpha}, and G15{alpha} on Vascular Smooth Muscle Cell Survival and Gene Expression Profiles
Mol. Pharmacol., June 1, 2005; 67(6): 2102 - 2114.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Fabbro, A. Skorinkin, M. Grandolfo, A. Nistri, and R. Giniatullin
Quantal release of ATP from clusters of PC12 cells
J. Physiol., October 15, 2004; 560(2): 505 - 517.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. KJAeR
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
Physiol Rev, April 1, 2004; 84(2): 649 - 698.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Lee, A. Robeva, Z. Chen, and K. P. Minneman
Mutational Uncoupling of {alpha}1A-Adrenergic Receptors from G Proteins Also Uncouples Mitogenic and Transcriptional Responses in PC12 Cells
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 471 - 477.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Bierhaus, J. Wolf, M. Andrassy, N. Rohleder, P. M. Humpert, D. Petrov, R. Ferstl, M. von Eynatten, T. Wendt, G. Rudofsky, et al.
A mechanism converting psychosocial stress into mononuclear cell activation
PNAS, February 18, 2003; 100(4): 1920 - 1925.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Bouschet, V. Perez, C. Fernandez, J. Bockaert, A. Eychene, and L. Journot
Stimulation of the ERK Pathway by GTP-loaded Rap1 Requires the Concomitant Activation of Ras, Protein Kinase C, and Protein Kinase A in Neuronal Cells
J. Biol. Chem., February 7, 2003; 278(7): 4778 - 4785.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Kalyankrishna and K. U. Malik
Norepinephrine-Induced Stimulation of p38 Mitogen-Activated Protein Kinase Is Mediated by Arachidonic Acid Metabolites Generated by Activation of Cytosolic Phospholipase A2 in Vascular Smooth Muscle Cells
J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 761 - 772.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. L. Berkeley and A. I. Levey
Cell-Specific Extracellular Signal-Regulated Kinase Activation by Multiple G Protein-Coupled Receptor Families in Hippocampus
Mol. Pharmacol., January 1, 2003; 63(1): 128 - 135.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Jiao, P. J. Gonzalez-Cabrera, L. Xiao, M. E. Bradley, P. W. Abel, and W. B. Jeffries
Tonic Inhibitory Role for cAMP in alpha 1a-Adrenergic Receptor Coupling to Extracellular Signal-Regulated Kinases 1/2
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 247 - 256.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Hague, P. J. Gonzalez-Cabrera, W. B. Jeffries, and P. W. Abel
Relationship between alpha 1-Adrenergic Receptor-Induced Contraction and Extracellular Signal-Regulated Kinase Activation in the Bovine Inferior Alveolar Artery
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 403 - 411.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Greney, D. Urosevic, S. Schann, L. Dupuy, V. Bruban, J.-D. Ehrhardt, P. Bousquet, and M. Dontenwill
[125I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I1 Imidazoline Receptors
Mol. Pharmacol., July 1, 2002; 62(1): 181 - 191.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Vanhoose, M. Emery, L. Jimenez, and D. G. Winder
ERK Activation by G-protein-coupled Receptors in Mouse Brain Is Receptor Identity-specific
J. Biol. Chem., March 8, 2002; 277(11): 9049 - 9053.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Zentrich, S.-Y. Han, L. Pessoa-Brandao, L. Butterfield, and L. E. Heasley
Collaboration of JNKs and ERKs in Nerve Growth Factor Regulation of the Neurofilament Light Chain Promoter in PC12 Cells
J. Biol. Chem., February 1, 2002; 277(6): 4110 - 4118.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. Wretman, A. Lionikas, U. Widegren, J. Lannergren, H. Westerblad, and J. Henriksson
Effects of concentric and eccentric contractions on phosphorylation of MAPKerk1/2 and MAPKp38 in isolated rat skeletal muscle
J. Physiol., August 15, 2001; 535(1): 155 - 164.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Esposito, S. V. N. Prasad, A. Rapacciuolo, L. Mao, W. J. Koch, and H. A. Rockman
Cardiac Overexpression of a Gq Inhibitor Blocks Induction of Extracellular Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase Activity in In Vivo Pressure Overload
Circulation, March 13, 2001; 103(10): 1453 - 1458.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Liu and F. A. Gesek
{alpha}1-Adrenergic receptors activate NHE1 and NHE3 through distinct signaling pathways in epithelial cells
Am J Physiol Renal Physiol, March 1, 2001; 280(3): F415 - F425.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Sabri, E. Pak, S. A. Alcott, B. A. Wilson, and S. F. Steinberg
Coupling Function of Endogenous {alpha}1- and {beta}-Adrenergic Receptors in Mouse Cardiomyocytes
Circ. Res., May 26, 2000; 86(10): 1047 - 1053.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Mulvaney and M. S. Roberson
Divergent Signaling Pathways Requiring Discrete Calcium Signals Mediate Concurrent Activation of Two Mitogen-activated Protein Kinases by Gonadotropin-releasing Hormone
J. Biol. Chem., May 5, 2000; 275(19): 14182 - 14189.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Zhong, T. J. Murphy, and K. P. Minneman
Activation of Signal Transducers and Activators of Transcription by alpha 1A-Adrenergic Receptor Stimulation in PC12 Cells
Mol. Pharmacol., May 1, 2000; 57(5): 961 - 967.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. M. Short, J. L. Boyer, and R. L. Juliano
Integrins Regulate the Linkage between Upstream and Downstream Events in G Protein-coupled Receptor Signaling to Mitogen-activated Protein Kinase
J. Biol. Chem., April 21, 2000; 275(17): 12970 - 12977.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. C. Blaxall, A. C. Pellett, S. C. Wu, A. Pende, and J. D. Port
Purification and Characterization of beta -Adrenergic Receptor mRNA-binding Proteins
J. Biol. Chem., February 11, 2000; 275(6): 4290 - 4297.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Cussac, A. Newman-Tancredi, V. Pasteau, and M. J. Millan
Human Dopamine D3 Receptors Mediate Mitogen-Activated Protein Kinase Activation Via a Phosphatidylinositol 3-Kinase and an Atypical Protein Kinase C-Dependent Mechanism
Mol. Pharmacol., November 1, 1999; 56(5): 1025 - 1030.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
N. L. Schramm and L. E. Limbird
Stimulation of Mitogen-activated Protein Kinase by G Protein-coupled alpha 2-Adrenergic Receptors Does Not Require Agonist-elicited Endocytosis
J. Biol. Chem., August 27, 1999; 274(35): 24935 - 24940.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. J. Della Rocca, S. Maudsley, Y. Daaka, R. J. Lefkowitz, and L. M. Luttrell
Pleiotropic Coupling of G Protein-coupled Receptors to the Mitogen-activated Protein Kinase Cascade. ROLE OF FOCAL ADHESIONS AND RECEPTOR TYROSINE KINASES
J. Biol. Chem., May 14, 1999; 274(20): 13978 - 13984.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Berts, H. Zhong, and K. P. Minneman
No Role for Ca++ or Protein Kinase C in Alpha-1A Adrenergic Receptor Activation of Mitogen-Activated Protein Kinase Pathways in Transfected PC12 Cells
Mol. Pharmacol., February 1, 1999; 55(2): 296 - 303.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. M. Lindquist, J. M. Fredriksson, S. Rehnmark, B. Cannon, and J. Nedergaard
beta 3- and alpha 1-Adrenergic Erk1/2 Activation Is Src- but Not Gi-mediated in Brown Adipocytes
J. Biol. Chem., July 21, 2000; 275(30): 22670 - 22677.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, N. G.
Right arrow Articles by Minneman, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, N. G.
Right arrow Articles by Minneman, K. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement